CIK 0001041024
- Non-accelerated filer
- Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383317208
- Phone
- +1 800-449-3353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-06-22 | HAGELSTEIN DAVID A 10% owner | Purchase | +3,600 | $8.55 | $31K | 1,353,700 |
| 2012-06-11 | KLEMA THOMAS E Vice President, CFO | Grant or award | +60,000 | 384,262 | ||
| 2012-06-11 | Gupta Ajay Chief Scientific Officer | Grant or award | +75,000 | 155,215 | ||
| 2012-06-11 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award | +100,000 | 1,056,333 | ||
| 2012-06-05 | HAGELSTEIN DAVID A 10% owner | Purchase | +100 | $8.75 | $875 | 1,342,800 |
| 2012-06-05 | HAGELSTEIN DAVID A 10% owner | Purchase | +1,697 | $8.75 | $15K | 1,344,497 |
| 2012-06-05 | HAGELSTEIN DAVID A 10% owner | Purchase | +400 | $8.79 | $4K | 1,344,897 |
| 2012-06-05 | HAGELSTEIN DAVID A 10% owner | Purchase | +3,803 | $8.80 | $33K | 1,348,700 |
| 2012-06-04 | KLEMA THOMAS E Vice President, CFO | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2012-06-04 | Gupta Ajay Chief Scientific Officer | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2012-06-04 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2012-05-24 | Pratt Raymond Dennis VP of Drug Development | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2012-01-06 | CHIOINI ROBERT L Chairman, President and CEO | Other disposition · Stock option (right to buy) | −36,000 | 107,000 | ||
| 2012-01-05 | KLEMA THOMAS E Vice President, CFO | Grant or award · Stock option (right to buy) | +75,000 | 75,000 | ||
| 2012-01-05 | HOLT KENNETH L Director | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2012-01-05 | Gupta Ajay Chief Scientific Officer | Grant or award · Stock option (right to buy) | +125,000 | 125,000 | ||
| 2012-01-05 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award · Stock option (right to buy) | +225,000 | 225,000 | ||
| 2012-01-05 | BOYD RONALD D Director | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2012-01-05 | Bagley Patrick J Director | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2011-11-21 | HAGELSTEIN DAVID A 10% owner | Purchase · Common Stock Warrant | +70,834 | $1.65 | $117K | 862,502 |
Page 28 of 30 · 588 trades